The main interest in our study was to find out if advice given to facilitate mourning after perinatal child loss (looking at the dead child, picture, burial) could be used to help parents terminating pregnancies for fetopathic reasons. To evaluate the acceptance and to compare the outcome in grief reactions we interviewed women undergoing termination of pregnancy for fetopathic reasons 1–2 days after the loss of the child and they answered a mailed questionnaire 8 weeks later. For comparison we assessed data from women with spontaneous child losses within the 12th to 24th week of pregnancy in a similar way. No difference in the extent of creating memories between the two groups of child losses could be assessed (44% of women after termination and 55% after spontaneous loss looked at their dead child). Making the dead baby a tangible person led to stronger grief reactions immediately after the loss without significant difference due to the kind of loss. But 8 weeks later women after spontaneous child losses reported significantly more mourning than those after termination. It could be shown that women do mourn after termination of pregnancy, that creating memories leads to more intense grief reactions shortly after the loss and that grief diminishes over time. The advice given to facilitate mourning after perinatal child loss can be transferred to parents dealing with termination of pregnancy for fetopathic reasons although coping seems to be more complicated in the latter situation.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.